Stimulation of collagen synthesis by the anabolic steroid stanozolol

Journal of Investigative Dermatology

Volumn 111, Issue 6, 1998, Pages 1193-1197

  Falanga, Vincent ^a,b,d   Greenberg, Adam S ^a   Zhou, Linda ^a   Ochoa, Sofia M ^a   Roberts, Anita B ^c   Falabella, Anna ^a   Yamaguchi, Yuji ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d ROGER WILLIAMS MEDICAL CENTER   (United States)

Author keywords

Fibroblasts; Transforming growth factor ; Wound healing

Indexed keywords

ANABOLIC AGENT; STANOZOLOL; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL VIABILITY; COLLAGEN SYNTHESIS; DRUG EFFECT; FIBROBLAST; HORMONE ACTION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SKIN FIBROBLAST; TISSUE REPAIR; WOUND HEALING;

EID: 0032456805     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1998.00431.x     Document Type: Article

References (29)

1. Beck LS, DeGuzman L, Lee WP, Xu Y, Siegel MW, Amento EP: One systemic administration of transforming growth factor-beta 1 reverses age- or glucocorticoid-impaired wound healing. J Clin Invest 92:2841-2849, 1993
2. Berger JR, Pall L, Winfield D: Effect of anabolic steroids on HIV-related wasting myopathy. South Med J 86:865-866, 1993
3. Browse NL, Jarrett PEM, Morland M, Burnand K: Treatment of liposclerosis of the leg by fibrinolytic enhancement: a preliminary report. Br Med J 2:434-435, 1977
4. Brunet CL, Sharpe PM, Ferguson MWJ: Inhibition of TGF-β3 (but not TGF-β1 or TGF-β2) activity prevents normal mouse embryonic palate fusion. Int J Dev Biol 39:345-355, 1995
5. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Chem 162:156-159, 1987
6. Chu M-L, Myers JC, Bernand MP, Ding J-F, Ramirez F: Cloning and characterization of five overlapping cDNAs specific for the human proalpha 1 (I) collagen chain. Nucl Acids Res 10:5925-5935, 1982
7. Derynck R, Jarrett JA, Ellson YC, et al: Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature 316:701-705, 1985
8. Ellis AJ, Cawston TE, Mackie EJ: The differential effects of stanozolol on human skin and synovial fibroblasts in vitro: DNA synthesis and receptor binding. Agents Actions 41:37-43, 1994
9. Falanga V, Tiegs SL, Alstadt SP, Roberts AB, Sporn MB: Transforming growth factor-beta: Selective increase in glycosaminoglycan synthesis by cultures of fibroblasts from patients with progressive systemic sclerosis. J Invest Dermatol 89:100-104, 1987
10. Falanga V, Kirsner RS, Eaglstein WH, Katz MH, Kerdel FA: Stanozolol in treatment of leg ulcers due to cryofibrinogenemia. Lancet 338:347-348, 1991
11. Falanga V, Martin TA, Takagi H, Kirsner RS, Helfman T, Pardes J, Ochoa S: Low oxygen tension increases mRNA levels of alpha 1 (I) procollagen in human dermal fibroblasts. J Cell Physiol 157:408-412, 1993
12. Glueck CJ, Freiberg R, Glueck HI, Tracy T, Stroop D, Wang Y: Idiopathic ostenonecrosis, hypofibrinolysis, high plasminogen activator inhibitor, high lipoproteinemia, and therapy with stanozolol. Am J Hematol 48:213-220, 1995
13. Gribbin HR, Flavell Matts SG: Mode of action and use of anabolic steroids. Br J Clin Practice 30:3-9, 1976
14. Hasan A, Murata H, Falabella A, Ochoa S, Zhou L, Badiavas E, Falanga V: Dermal fibroblasts from venous ulcers are unresponsive to the action of transforming growth factor-β 1. J Dermatol Sci 16:59-66, 1997
15. Helfman T, Falanga V: Stanozolol as a novel therapeutic agent in dermatology. J Am Acad Dermatol 32:254-258, 1995
16. Hosegood JL, Franks AJ: Response of human skeletal muscle to the anabolic steroid stanozolol. Br Med J 297:1028-1029, 1988
17. Kim CS, Buchmiller TL, Fonkalsrud EW, Phillips JD: The effect of anabolic steroids on ameliorating the adverse effects of chronic corticosteroids on intestinal anastomotic healing in rabbits. Surg Gyn Obstet 176:73-79, 1993
18. Kirsner RS, Eaglstein WH, Katz MH, Kerdel FA, Falanga V: Stanozolol causes rapid pain relief and healing of cutaneous ulcers caused by cryofibrinogenemia. J Am Acad Dermatol 28:71-74, 1993
19. Kulkarni AB, Hugh CG, Becker D, et al: Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90:770-774, 1993
20. Miskulin M, Dagleish R, Kluve-Beckermann B, Rennard SI, Tostoshev P, Brantly M, Crystal RG: Human type III collagen gene expression is coordinately modulated with type I collagen genes during fibroblast growth. Biochem 25:1408-1413, 1986
21. Murata H, Zhou L, Ochoa S, Hasan A, Badiavas E, Falanga V: TGF-β3 stimulates and regulates collagen synthesis through TGF-β1 dependent and independent mechanisms. J Invest Dermatol 108:258-262, 1997
22. Mustoe TA, Pierce GF, Thomason A, Gramates P, Sporn MB, Deuel TF: Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science 237:1333-1336, 1987
23. Roberts AB, Sporn MB, Assoian RK, et al: Transforming growth factor type beta. Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci 83:4167-4171, 1986
24. Takagi H, Ochoa S, Zhou L, Helfman T, Murata H, Falanga V: Enhanced collagen synthesis and transcription by peak E, a contaminant of L-tryptophan preparations associated with the EMS epidemic. J Clin Invest 96:2120-2125, 1995
25. Varga J, Rosenbloom J, Jimenez SA: Transforming growth factor beta (TGF-beta) causes a persistent increase in steady state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem J 247:597-604, 1987
26. Watts GT, Baddeley RB, Wellings R, Evans J: The nature of wound healing: experimental tensile strength studies with deca durabolin and S35. Ann Surg 162:109-112, 1965
27. Webster DF, Harvey WA: quantitative assay for collagen synthesis in micro well fibroblast cultures. Anal Biochem 96:220-224, 1979
28. Wilson J: Androgens. In: Gilman AG, Rall TW, Nies AS, et al (eds). Goodman and Gilman's Pharmacological Basis of Therapeutics. New York: Pergamon Press, 1990, pp. 1413-1430
29. Wright JK, Smith AJ, Cawston TE, Hazleman BL: The effect of the anabolic steroid, stanozolol, on the production of procollagenase by human synovial and skin fibroblasts in vitro. Agents Actions 28:279-282, 1989